Increased fibrosis and microvessel disease in allograft endomyocardial biopsies of children with chronic graft failure due to cardiac allograft vasculopathy.

[1]  E. Grove,et al.  CORONARY FLOW VELOCITY RESERVE AND MYOCARDIAL DEFORMATION PREDICT LONG-TERM OUTCOME IN HEART TRANSPLANT RECIPIENTS. , 2021, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[2]  A. Kfoury,et al.  Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy , 2018, Circulation. Heart failure.

[3]  A. Demetris,et al.  Late graft dysfunction after pediatric heart transplantation is associated with fibrosis and microvasculopathy by automated, digital whole-slide analysis. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  A. Dipchand,et al.  Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients , 2017, Journal of Cardiovascular Magnetic Resonance.

[5]  C. Gleissner,et al.  Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy. , 2016, JACC. Cardiovascular imaging.

[6]  X. Jouven,et al.  Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody‐Mediated Rejection , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  G. Ottaviani,et al.  Pathological assessment of end-stage heart failure in explanted hearts in correlation with hemodynamics in patients undergoing orthotopic heart transplantation. , 2015, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[8]  G. Gerosa,et al.  Coronary Microvascular Dysfunction Correlates With the New Onset of Cardiac Allograft Vasculopathy in Heart Transplant Patients With Normal Coronary Angiography , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  L. Stoletniy,et al.  Lack of Relationship Between Microvascular and Macrovascular Disease in Heart Transplant Recipients , 2012, Transplantation.

[10]  A. Angelini,et al.  Recent developments on coronary microvasculopathy after heart transplantation: a new target in the therapy of cardiac allograft vasculopathy. , 2012, Current vascular pharmacology.

[11]  M. Fishbein,et al.  Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  R. Starling,et al.  International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  M. Fishbein,et al.  Clinico‐pathologic findings in end‐stage pediatric heart transplant grafts , 2009, Pediatric transplantation.

[14]  S. Williams,et al.  The Pathophysiology of Chronic Graft Failure in the Cardiac Transplant Patient , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  M. Zembala,et al.  Microvasculopathy observed in early or late endomyocardial biopsies is not related to angiographically confirmed transplanted heart coronary vasculopathy. , 2009, Transplantation proceedings.

[16]  W. Kremers,et al.  Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  E. Wellnhofer,et al.  Coronary flow reserve measurement detects transplant coronary artery disease in pediatric heart transplant patients. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  E. Wellnhofer,et al.  Prognostic Impact of Microvasculopathy on Survival After Heart Transplantation: Evidence From 9713 Endomyocardial Biopsies , 2007 .

[19]  W. Baldwin,et al.  Update on cardiac transplantation pathology. , 2007, Archives of pathology & laboratory medicine.

[20]  E. Tuzcu,et al.  Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome. , 2002, Journal of the American College of Cardiology.

[21]  W. Roberts,et al.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. , 1986, Journal of the American College of Cardiology.